To validate the findings in human gastric cancer specimens, we first analyzed the expression levels of IGF2BP3 and MUC16 in 13 GLP and 30 gastric cancer tissues using immunohistochemistry. The gene discussed is IGF2BP3; the disease is gastric cancer.